Dedicated To Discovery

Committed To Care

Advancement of Technology for Jubilant and Healthy Life

Bertis develops early detection technologies
for cancer and other major diseases.
Since its foundation in 2014, Bertis has been conducting the most advanced quantitative proteomics studies.
The company establishes a foundation for precision medicine by developing diagnostic solutions based on technology that combines proteomics and AI.

Learn more

We value human dignity and self-esteem and
contribute to family happiness and society
Bertis develops technologies to diagnose and treat disease using information contained in a very small amount of blood.
From the era of “treatment,” we will lead the world into the era of “diagnosis” and “prevention.”
go top